Y. Kang

Pharmacogenomics and Personalized Medicine

Y. Kang, L. Leggio, W. Zywiak, 2008, Methods in Pharmacology and Toxicology.

Principles and Methods of Cardiac Toxicology

Y. Kang, 2007 .

Rhabdomyolysis associated with initiation of febuxostat therapy for hyperuricaemia in a patient with chronic kidney disease

M. Kim, Y. Kang, D. Park, 2014, Journal of clinical pharmacy and therapeutics.

The Relationship between Mast Cell Density and Tumour Grade in Transitional Cell Carcinoma of the Bladder

Y. Kang, Ds Kim, J. H. Kim, 2011, The Journal of international medical research.

Extracellular matrix remodeling is associated with the survival of cardiomyocytes in the subendocardial region of the ischemic myocardium

Y. Kang, Ying Xiao, Qing Chu, 2021, Experimental biology and medicine.

Rejuvenation: an integrated approach to regenerative medicine

Y. Kang, Lily Zheng, James Kang, 2013, Regenerative Medicine Research.

Molecular Medicine: An Introductory Text, 3rd Edition

Y. Kang, 2006, Environmental Health Perspectives.

Effect of buthionine sulfoximine on the response to arsenic deprivation in female rats

Y. Kang, E. Uthus, 1998 .